CockSparrow was a G-3 who had null response two times and went on to SVR.
He knew a heck of a lot about G-3's (and the related studies) and I wonder what he'd advise about you skipping a dose. I wish I could ask him.
He said, "Whats also clear is that G3s who RVR are dead easy to treat, at least as easy as G2s." I think he based that on the highly complex Berg study.
http://www.medhelp.org/posts/Hepatitis-C/3a-Riba-dosage/show/481276
"Tailored Treatment for Hepatitis C" by Thomas Berg, MD
"It is no longer appropriate to generalize that patients who have HCV genotype 1 and 4 are ‘‘difficult to cure’’ because of viral kinetic evidence to the contrary. Conversely, it is no longer appropriate to think of all patients who have HCV genotype 2 or 3 as ‘‘easy to cure.’’ Although genotype is an important driver of response and is useful in designing the initial treatment plan, it is clear that once treatment is initiated, RVR is the most important and powerful predictor of SVR."
Even though you've got such AMAZING predictors working for you, zero fibrosis, starting viral load of 50,000 (!), undetected after three weeks of meds, maybe earlier, female, I'm stumped why the doc would intervene with those numbers and not give you a study to support his decision or refer you to some sort of published guideline. And why didn't he offer a dose reduction instead of skipping it entirely? :(
I hope you keep us posted.
Susan